Skip to main content
Equibles
NGNE logo

NGNE · Neurogene Inc. · Metrics

Track NGNE — free

Use NGNE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NGNE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$27.58 +0.91 (+3.41%)
Russell 2000 member Rebalance outlook locked
Market Cap
$533.70M
Shares
20.01M
Volume · Nov 4 208.56K Avg daily vol (3M) 291.93K

NGNE metrics

69 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$26.67
Market cap
$533.70M

Price action

20 metrics
Price change (1W)
-1.2%
Price change (30D)
+0.8%
Price change (3M)
-22.5%
Price change (6M)
-7.8%
Price change (YTD)
+29.5%
Price change (1Y)
-14.1%
Trailing year
Price change (5Y)
—
52-week high
$42.84
52-week low
$16.37
Change from 52-week high
-37.7%
Change from 52-week low
+62.9%
Annualized volatility
78.7%
Annualized volatility (3M)
75.9%
Beta
1.7
RSI (14D)
48.6
Price vs SMA 50
-11.8%
Price vs SMA 200
-4.4%
Avg volume (3M)
291,930
Relative volume
0.6
Average dollar volume
$9.07M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
20.01M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.5
reciprocal yield 40.7%
FCF yield
-16.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-20.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-08-11

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$121.35M
Net income (TTM)
−$111.11M
Trailing 12 months
Diluted EPS (TTM)
$-5.03
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-5.49
EBITDA per diluted share (TTM)
$-5.35
Net income per diluted share (TTM)
$-5.03
Operating cash flow per diluted share (TTM)
$-3.94
Free cash flow per diluted share (TTM)
$-3.98
Capital expenditures per diluted share (TTM)
$0.04
R&D per diluted share (TTM)
$4.01
Stock compensation per diluted share (TTM)
$0.82
Book value per share
$17.10

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+7.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-51.2%
Return on assets
-45.5%
Debt / equity
0.0
Current ratio
10.6
EBITDA (TTM)
−$118.19M
Free cash flow (TTM)
−$87.71M
Quick ratio
10.6
Interest coverage
-60,673.5
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$225.38M
Latest balance sheet
Cash & equivalents
$112.48M
Total assets
$244.36M
Total debt
$8,000

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$86.82M
Capital expenditures (TTM)
$890,000
R&D (TTM)
$88.50M
SG&A (TTM)
—
Stock compensation (TTM)
$18.22M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
112
13F filer change QoQ
+14
Institutional ownership
87.2%
Conviction holders (share of 13F filers)
3.6%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.0%
Holder tenure
8.5
Price vs estimated holder cost
+18.0%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.7%

Short interest

3 metrics
Short interest
25.5%
Latest settlement · 14.4 days to cover
Days to cover
14.4d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1404644 CUSIP 64135M105 13F (30d) 23 filings 23 filers Visit website Investor relations